Company Overview of JLL Partners
JLL Partners is a private equity firm specializing in investments in middle market companies. The firm prefers to invest in balance sheet restructurings, debt financing, buyouts, recapitalization, corporate divestitures, operational turnarounds, acquisitions, bolt-on acquisitions, add-on acquisitions, industry consolidations, and strategic co-investments. It invests in companies which are significantly over-leveraged; companies lacking committed sponsorship; companies requiring strategic and/or operational refocusing; companies in out-of-favor industries; businesses being divested from a larger corporate entity; and companies seeking a financial partner to pursue their strategies. The firm s...
450 Lexington Avenue
New York, NY 10017
Founded in 1988
Key Executives for JLL Partners
Co-Founder, Managing Director, and Managing Partner
Chief Financial Officer and Controller
Managing Director and member of Investment Committee
Managing Director and Member of Investment Committee
Managing Director and Partner
Compensation as of Fiscal Year 2016.
JLL Partners Key Developments
BioClinica Reportedly Explores Sale
May 26 16
BioClinica, Inc., owned by buyout firm JLL Partners, is exploring a sale that could value it at as much as $1.3 billion, including debt, according to people familiar with the matter. BioClinica has hired investment bank Jefferies LLC to run an auction for the company, the people said, declining to be identified because the discussions are private. JLL Partners declined to comment. Jefferies and BioClinica did not immediately respond to requests for comment.
DPx Holdings Plans IPO
Jun 8 15
JLL Partners -backed DPx Holdings B.V. filed plans for an initial public offering, according to a filing with the Securities and Exchange Commission. The number of shares on offer and the price range for the IPO haven't yet been determined, according to the regulatory filing. The document lists a proposed maximum offering amount of $100 million, a figure often used as a place holder in regulatory filings made before the announcement of the number of shares being offered and their potential price range.
Similar Private Companies By Industry
Recent Private Companies Transactions
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries